Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
And that counts swap The main investor, together with the group Investors Among them are Norwest and HarbourWest. Parthenon and Bain Capital will remain the company’s primary owners.
In this regard, Mina Hamoudi, head of the investment department, said health care On Mubadala: “We are pleased to announce our investment in the company.” ZelesIt is a company that has set itself apart by providing integrated solutions for issues related to payment systems in the healthcare sector. “Zelis is helping to simplify the complex financial processes in the US healthcare industry, through technology solutions that enable greater efficiency and improved outcomes for all parties involved in the care journey.”
Hamoudi added: “This is our largest investment in the health sector and our first important step in this area.” Technology Which serves providers and recipients of healthcare services, and is one of our priority sub-sectors in the area of information technology in the healthcare sector. We look forward to working with one of the most respected management teams in the healthcare industry, along with Parthenon and Bain Capital, and contributing to the continued success of Zilis.
“Zelis has a unique ability to serve the interests of payers, healthcare providers and members in a way that lowers costs and improves health care outcomes,” said Amanda Issel, CEO of Zelis. She added, “I look forward to working with Mubadala and other new investors in our efforts to positively impact the US healthcare system and improve the efficiency of the healthcare system.”
Ziliss modernizes healthcare financial systems by providing an integrated platform that bridges the gaps and interests of healthcare payers, providers and consumers. This platform serves more than 750 payers, including the nation’s top 5 health programs and companies Insurance BCBS, regional health programs, third party administration companies (TPAs), self-insured employers, as well as millions of providers and consumers in the healthcare industry. Zelis has a comprehensive vision that enables it to identify problems, solve them, improve performance and deliver comprehensive solutions using technologies designed by healthcare professionals – and achieve tangible results for its clients.
Goldman Sachs & Co. LLC (Goldman Sachs) and J.P. Morgan Securities LLC (JP Morgan) served as financial advisor to Zelis, while Kirkland & Ellis LLP provided legal counsel. On the other hand, Evercore served as financial advisor and Akin Gump Strauss Hauer & Feld LLP served as legal advisor to Mubadala. The transaction closed on November 26, 2024.